GoodRx Inc.

NASDAQ: GDRX · Real-Time Price · USD
3.75
0.21 (5.93%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.67%
After-hours: Aug 15, 2025, 06:47 PM EDT

GoodRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
792.32M 750.26M 766.55M 745.42M
Cost of Revenue
48.22M 66.92M 65.08M 46.72M
Gross Profit
744.11M 683.34M 701.48M 698.71M
Operating Income
65.85M -27.01M 11.01M 13.41M
Interest Income
23.27M 32.17M 9.27M 59K
Pretax Income
31.46M -55.57M -23.23M -10.18M
Net Income
16.39M -8.87M -32.83M -25.25M
Selling & General & Admin
464.62M 466.84M 502.42M 524.9M
Research & Development
123.75M 135.84M 143.14M 125.86M
Other Expenses
69.54M 107.67M 54.18M 34.54M
Operating Expenses
678.26M 710.35M 699.74M 685.3M
Interest Expense
52.92M 56.73M 34.24M 23.64M
Selling & Marketing Expenses
367.11M 341.33M 357.63M 370.22M
Cost & Expenses
726.48M 777.27M 764.82M 732.02M
Income Tax Expense
15.07M -46.7M 9.6M 15.08M
Shares Outstanding (Basic)
385.74M 410.31M 412.86M 400.56M
Shares Outstanding (Diluted)
392.17M 410.31M 412.86M 400.56M
EPS (Basic)
0.04 -0.02 -0.08 -0.06
EPS (Diluted)
0.04 -0.02 -0.08 -0.06
EBITDA
153.92M 108.82M 68.54M 48M
EBIT
84.38M 1.16M 11.01M 13.41M
Depreciation & Amortization
69.54M 107.67M 57.53M 37.64M